Mark D Reeth Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark D Reeth.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark D Reeth. Mark D Reeth is Gen Counsel&VP Corp Compliance in SALIX PHARMACEUTICALS LTD ($SLXP).
Latest Insider Trading Transactions of Mark D Reeth
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2011 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Sell | S | 40.32 | 7,357 | 296,670 | 35,591 | 42.9 K to 35.6 K (-17.13 %) |
Jul 06 2011 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Payment of Exercise | F | 39.83 | 4,180 | 166,489 | 42,948 | 47.1 K to 42.9 K (-8.87 %) |
May 04 2011 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Payment of Exercise | F | 39.29 | 1,623 | 63,768 | 50,505 | 52.1 K to 50.5 K (-3.11 %) |
May 04 2011 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Grant | A | 0.00 | 8,450 | 0 | 52,128 | 43.7 K to 52.1 K (+19.35 %) |
May 17 2011 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Sell | S | 39.84 | 3,377 | 134,535 | 47,128 | 50.5 K to 47.1 K (-6.69 %) |
Jul 21 2010 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Grant | A | 0.00 | 7,930 | 0 | 43,678 | 35.7 K to 43.7 K (+22.18 %) |
Jul 06 2010 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Payment of Exercise | F | 39.03 | 3,536 | 138,010 | 35,748 | 39.3 K to 35.7 K (-9.00 %) |
Jun 15 2010 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Sell | S | 36.24 | 4,278 | 155,030 | 39,284 | 43.6 K to 39.3 K (-9.82 %) |
May 19 2010 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Sell | S | 37.38 | 3,377 | 126,226 | 43,562 | 46.9 K to 43.6 K (-7.19 %) |
May 05 2010 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Payment of Exercise | F | 40.15 | 1,623 | 65,163 | 46,939 | 48.6 K to 46.9 K (-3.34 %) |
Nov 24 2009 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Sell | S | 23.64 | 3,377 | 79,849 | 48,562 | 51.9 K to 48.6 K (-6.50 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Grant | A | 0.00 | 18,240 | 0 | 51,939 | 33.7 K to 51.9 K (+54.13 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Payment of Exercise | F | 9.87 | 2,056 | 20,293 | 33,699 | 35.8 K to 33.7 K (-5.75 %) |
May 01 2009 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Payment of Exercise | F | 11.00 | 1,623 | 17,853 | 35,755 | 37.4 K to 35.8 K (-4.34 %) |
Jul 03 2008 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Grant | A | 0.00 | 19,000 | 0 | 37,378 | 18.4 K to 37.4 K (+103.38 %) |
May 05 2008 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Sell | S | 7.16 | 1,622 | 11,617 | 18,378 | 20 K to 18.4 K (-8.11 %) |
May 16 2007 | SLXP | SALIX PHARMACEUTIC ... | Reeth Mark D | Gen Counsel&VP Corp ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Page: 1